Article ID Journal Published Year Pages File Type
10837961 Pharmacology Biochemistry and Behavior 2011 8 Pages PDF
Abstract
► Varenicline is a partial agonist at α4β2 and full agonist at α7 nicotinic receptors. ► Varenicline improves a sensory inhibition deficit in DBA/2 mice. ► Improvement is via activation of α4β2 with an indication for α7 involvement.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Preview
The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice
Authors
, ,